International Funded Projects

Institution Role of Institution Funding Institution Reference Designation Principal Investigator

International Projects
FFUL Proponent H2020-WIDESPREAD-2018-2020 / H2020-WIDESPREAD-2020-5 GA 951996 Straightening Training, Research and Innovation Capacities in the Valorization of Bio-Renewable Resources (Biomass4Synthons)

Carlos Alberto Mateus Afonso

FFUL Proponent Science for Peace and Security (SPS) NATO Program SPS G5713 Biofriendly Decontamination of Chemical Warfare Agents (EnzIL)

Carlos Alberto Mateus Afonso

FFUL Proponent European Society of Clinical Microbiology and Infectious Diseases (ESCMID) ESCMID Research Grant 2018 Decoding the peptidoglycan patterns associated with beta-lactams hypersusceptibility in drug-resistant Mycobacterium tuberculosis

FFUL Participant Comissão Europeia LIFE-Environment and Resource Efficiency | GA LIFE14 ENV/PT/000739 Improving current barriers for controlling pharmaceutical compounds in urban wastewater treatment plants

Cristina Maria Martins de Almeida

FFUL Participant Horizonte 2020 Marie Sklodowska Curie Innovative Actions - Training Networks | H2020-MSCA-ITN-2016_GA_722619 Bioenergetic remodelling in the pathophysiology and treatment of non-alcoholic fatty liver disease

Cecília Maria Pereira Rodrigues

FFUL Participant Horizonte 2020 Marie Sklodowska Curie Actions - Innovative Training Networks | MSCA-ITN-2015-ETN-675007 A training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates

Pedro Miguel Pimenta Góis

FFUL Participant Horizonte 2020 Marie Sklodowska Curie Actions - Research and Innovation Staff Exchange | H2020-MSCA-RISE-2016_GA_ 734719 Non-invasive Profiling of Mitochondrial Function in Non-Alcoholic Fatty Liver Disease

Cecília Maria Pereira Rodrigues

FFUL Participant Horizonte 2020 Innovative Medicines Initiative 2 | H2020-JTI-IMI2-2016-09-two-stage_GA_777377 Identification and validation of biomarkers for non-alcoholic steatohepatitis (NASH) and across the spectrum of non-alcoholic fatty liver disease (NAFLD)

Cecília Maria Pereira Rodrigues

Share